| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785043 | Advances in Radiation Oncology | 2016 | 7 Pages |
Abstract
CRT with DTX might be a treatment option for elderly patients with stage II/III esophageal cancer, particularly for patients who are medically unfit for surgery or cisplatin-containing therapy. However, further improvements of this therapy are required to decrease the incidence of esophagitis.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Akihiro MD, Ken MD PhD, Yoshinori MD, Chikatoshi MD PhD, Hiromichi MD PhD, Sachiko MD, Takashi MD, Takeshi MD PhD, Shigehiro MD, Yoshio MD PhD,